🔗 Permalink

Inventor profile of:

Michael D. Kaufman

City:

Lawrence, Kansas

Country:

United States

Published Applications:

44

Last publication date:

2022-02-03

Top Assignees for applications by Michael D. Kaufman

The entities that hold a legal rights for patent applications filed by inventor Kaufman Michael D.:

DECIPHERA PHARMACEUTICALS, LLC 27 Lawrence, KS United States
DECIPHERA PHARMACEUTICALS, INC. 3 Lawrence, KS United States
DECIPHERA PHAMACEUTICALS, LLC 1 Lawrence, KS United States
Deciphera Parmaceuticals, LLC 1 Lawrence, KS United States
Deciphera Pharmaceuticals, LLC 1 Waltham, MA United States
Deciphera Pharmaceuticals, LLS 1 Lawrence, KS United States
Deciphera Pharmaceuticals, LLC 1 Lawrence, KC, -
Deciphera Pharmaceuticals, LLC 1 , KS United States
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 1 PHILADELPHIA, PA United States
Eli Lilly and Company 1 , IN United States
ELI LILLY AND COMPANY 1 Indianapolis, IN United States

Recent patent applications by Kaufman Michael D.

Michael D. Kaufman from Lawrence, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-02-03

US20220031678A1

Human necessities

USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA

#2 | 2021-01-21

US20210015801A1

Human necessities

USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA

#3 | 2020-04-30

US20200129489A1

Human necessities

USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA

#4 | 2019-03-28

US20190091217A1

Human necessities

METHODS FOR INHIBITING TIE-2 KINASE USEFUL IN THE TREATMENT OF CANCER

#5 | 2017-07-27

US20170209428A1

Human necessities

METHODS FOR INHIBITING TIE-2 KINASE USEFUL IN THE TREATMENT OF CANCER

#6 | 2017-03-23

US20170079966A1

Human necessities

INHIBITION OF TUMOR CELL INTERACTIONS WITH THE MICROENVIRONMENT RESULTING IN A REDUCTION IN TUMOR GROWTH AND DISEASE PROGRESSION

#7 | 2016-04-14

US20160101090A1

Human necessities

INHIBITION OF TRK KINASE MEDIATED TUMOR GROWTH AND DISEASE PROGRESSION

#8 | 2016-02-18

US20160046619A1

Chemistry; metallurgy

IMIDAZOLIDINONES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES

#9 | 2015-11-12

US20150320759A1

Human necessities

DIHYDRONAPHTHYRIDINES AND RELATED COMPOUNDS USEFUL AS KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

#10 | 2015-09-03

US20150246033A1

Human necessities

Methods for inhibiting tie-2 kinase useful in the treatment of cancer

#11 | 2015-08-06

US20150218130A1

Chemistry; metallurgy

CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES

#12 | 2015-05-28

US20150148380A1

Human necessities

Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

#13 | 2015-04-30

US20150119392A1

Chemistry; metallurgy

RAF inhibitor compounds

#14 | 2015-04-16

US20150105367A1

Chemistry; metallurgy

Raf inhibitor compounds

#15 | 2014-11-20

US20140343103A1

Chemistry; metallurgy

Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

#16 | 2014-10-23

US20140315917A1

Chemistry; metallurgy

Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities

#17 | 2014-10-02

US20140296252A1

Chemistry; metallurgy

1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities

#18 | 2014-09-18

US20140275085A1

Chemistry; metallurgy

2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities

#19 | 2014-09-18

US20140275080A1

Chemistry; metallurgy

N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities

#20 | 2014-09-18

US20140275016A1

Chemistry; metallurgy

N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities

#21 | 2014-07-10

US20140194405A1

Chemistry; metallurgy

CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES

#22 | 2014-03-27

US20140088075A1

Chemistry; metallurgy

Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

#23 | 2013-11-28

US20130317066A1

Chemistry; metallurgy

Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

#24 | 2013-09-26

US20130252977A1

Chemistry; metallurgy

Raf inhibitor compounds

#25 | 2013-06-11

US13491394

Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

#26 | 2013-03-28

US20130079362A1

Chemistry; metallurgy

Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities

#27 | 2012-12-20

US20120322834A1

Chemistry; metallurgy

Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities

#28 | 2012-11-15

US20120289540A1

Human necessities

KINASE INHIBITORS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES

#29 | 2012-10-04

US20120252849A1

Chemistry; metallurgy

CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES

#30 | 2012-09-06

US20120225057A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES

#31 | 2012-07-05

US20120172382A1

Chemistry; metallurgy

Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

#32 | 2012-03-08

US20120058985A1

Chemistry; metallurgy

CYCLOPROPYL DICARBOXAMIDES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES

#33 | 2011-08-04

US20110189167A1

Human necessities

Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases

#34 | 2011-06-09

US20110136760A1

Chemistry; metallurgy

Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases

#35 | 2011-05-19

US20110118271A1

Chemistry; metallurgy

Kinase Inhibitors Useful For The Treatment Of Proliferative Diseases

#36 | 2010-05-13

US20100120806A1

Chemistry; metallurgy

N-acyl ureas exhibiting anti-cancer and anti-proliferative activities

#37 | 2009-07-23

US20090187031A1

Chemistry; metallurgy

Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof

#38 | 2009-04-16

US20090099190A1

Chemistry; metallurgy

Kinase inhibitors useful for the treatment of proliferative diseases

#39 | 2008-10-30

US20080269267A1

Chemistry; metallurgy

KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFIC DISEASES AND OTHER PROLIFERATIVE DISEASES

#40 | 2008-10-30

US20080269254A1

Chemistry; metallurgy

KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFIC DISEASES AND OTHER PROLIFERATIVE DISEASES

#41 | 2008-10-23

US20080261965A1

Chemistry; metallurgy

Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases

#42 | 2008-10-23

US20080261961A1

Chemistry; metallurgy

KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFIC DISEASES AND OTHER PROLIFERATIVE DISEASES

#43 | 2008-05-15

US20080114006A1

Human necessities

Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

#44 | 2008-04-17

US20080090856A1

Chemistry; metallurgy

Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases

InventorID:

167519 ⎘